Latest Breaking News On - Remi barbier - Page 5 : comparemela.com

Cassava Sciences (SAVA) Reports Q3 EPS of ($0 61), Provides Update

Cassava Sciences (SAVA) Reports Q3 EPS of ($0 61), Provides Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesEric schoenRemi barbierCassava sciences incCassava sciencesCassava scienceSafety monitoring boardThird quarterMore information contactChief financialNote regarding forward looking statementsPrivate securities litigation reform actAnnual reportFinancial tables follow

Cassava Sciences Reports Third Quarter 2023 Financial and Operating Results

07.11.2023 - Enrollment completed for Phase 3 trials evaluating oral simufilam in Alzheimer s.Over 1,900 patients randomized in on-going Phase 3 trials.Top-line results for 52-week Phase 3 trial expected approximately year-end 2024; top-line results for 76-week .

United statesRemi barbierEric schoenCassava sciencesCassava sciences incCassava scienceSafety monitoring boardThird quarterMore information contactChief financialNote regarding forward looking statementsPrivate securities litigation reform actAnnual reportFinancial tables follow

Cassava Sciences Completes Enrollment for Pivotal Phase 3 Program of Simufilam in Alzheimer s Disease -November 06, 2023 at 09:16 am EST

1,929 patients randomized in a pair of Phase 3 trials to evaluate oral simufilam in Alzheimer s disease dementia.Top-line results for on-going, 52-week Phase 3 trial expected approximately year-end.

South koreaUnited statesPuerto ricoRemi barbierEric schoenCassava sciences incCassava sciencesResearch internationalCassava scienceSpecial protocol assessmentPremier research internationalSafety monitoring boardMore information contactChief financialNote regarding forward looking statementsPrivate securities litigation reform act

CUNY Halts Investigation of Alzheimer s Researcher

Citing questions about the integrity of the process, the university said that “no final action” had been taken.

United statesNew yorkRemi barbierLindsayh burnsHoau yan wangExchange commissionCassava sciencesNational institutes of healthCity university of new yorkCity universityNational institutesYour feed scienceEthics misconduct malfeasanceAlzheimer x27 sClinical trial

$500m Alzheimer s drug scandal: NY scientist behind NIH-funded therapy busted for allegedly manipulating data in 20 research papers - now there are calls for trials to be cut off

Scientists are calling for stage 3 clinical trials of an Alzheimer s drug to be scrapped after a report highlighted serious doubts about the legitimacy of research that helped the medicine reach that stage.

United kingdomNew yorkUnited statesVincent boudreauHoau yan wangKevin gardnerRemi barbierDee mozeleskiMatthew schragDavid bredtLindsay burnsGeoffrey pittJennifer beidel scramlinNational institutes of healthCity university of new yorkCassava sciences